Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Humasis CoXKRX:205470 +2.95%42 OCF Margin % is 46.50% as of Jun. 2026, which is 134% above its 10-year median of 19.90. GuruFocus rates XKRX:205470 with a GF Score™ of 42/100 and a GF Value™ of ₩9,890.20 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 813 Medical Devices & Instruments companies, Humasis Co ranks better than 97.54% on this metric.
The historical rank and industry rank for Humasis Co's OCF Margin % or its related term are showing as below:
XKRX:205470'
s OCF Margin % Range Over the Past 10 Years
Min: -401.25 Med: 19.9 Max: 98.18
Current: 39.88
During the past 12 years, the highest OCF Margin % of Humasis Co was 98.18%. The lowest was -401.25%. And the median was 19.90%.
XKRX:205470's OCF Margin % is ranked better than 97.54% of 813
companies
in the Medical Devices & Instruments industry
Industry Median: 6.64
vs XKRX:205470: 39.88
The historical data trend for Humasis Co's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XKRX:205470 vs ABT, SYK, MDT: OCF Margin % Comparison
For the Medical Devices subindustry, Humasis Co's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Humasis Co OCF Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Humasis Co's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Humasis Co's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Humasis Co (XKRX:205470) has a OCF Margin % of 46.50% as of Jun. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Humasis Co and its competitors. This is 134% above median its historical median of 19.90. According to the industry distribution chart, Humasis Co ranks #20 out of 813 companies in the Medical Devices & Instruments industry, placing it in the top 2.5%.
Is Humasis Co's OCF Margin % too high?
Humasis Co's current OCF Margin % of 46.50% is 134% above median its 10-year median of 19.90. The Medical Devices & Instruments industry median OCF Margin % is 6.64. Humasis Co's value of 46.50% is 600.3% above this industry median. Based on the distribution chart, Humasis Co ranks #20 out of 813 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Humasis Co has a GF Score™ of 42/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Humasis Co's OCF Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Humasis Co ranks #20 out of 813 companies for OCF Margin %. This places Humasis Co in the top 3% of its industry — outperforming the majority of peers. The industry median OCF Margin % is 6.64. Humasis Co's value of 46.50% is 600.3% above this benchmark. While the company's 10-year median is 19.90 vs. the industry median of 6.64, Humasis Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Medical Devices & Instruments company?
The median OCF Margin % among Medical Devices & Instruments companies is 6.64, based on 813 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Humasis Co's current OCF Margin % of 46.50% is 600.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Humasis Co and its competitors. For the Medical Devices & Instruments industry, the median OCF Margin % is 6.64 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Humasis Co's current OCF Margin % is 46.50%, which is 134% above median its own 10-year median of 19.90. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Humasis Co stock overvalued right now?
Based on GuruFocus' analysis, Humasis Co (XKRX:205470) is currently considered Possible Value Trap. The stock's GF Value™ is ₩9,890.20, compared to a current price of ₩3,310.00 — trading 66.5% below its estimated fair value. The current OCF Margin % is 46.50%, which is 134% above median its 10-year median of 19.90 and 600.3% above the Medical Devices & Instruments industry median of 6.64. Humasis Co's overall GF Score™ is 42/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Humasis Co (XKRX:205470), the current OCF Margin % is 46.50% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Humasis Co (XKRX:205470) Overvalued in 2026?
Based on GuruFocus' analysis, Humasis Co stock appears to be undervalued.
The current stock price of ₩3,310.00 is trading 66.5% below its estimated GF Value™ of ₩9,890.20.
GuruFocus considers Humasis Co to be Possible Value Trap.
Key valuation signals for XKRX:205470:
OCF Margin %: 46.50% (134% above median its 10-year median of 19.90)
GF Value™: ₩9,890.20 vs. price of ₩3,310.00 (66.5% below fair value)
Industry Position: 600.3% above the Medical Devices & Instruments median (#20 of 813)
No single metric tells the full story. See the XKRX:205470 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKRX:205470 has been successfully added to your 
